...
首页> 外文期刊>The Journal of Nuclear Medicine >Evaluation of in vivo P-glycoprotein function at the blood-brain barrier among MDR1 gene polymorphisms by using 11C-verapamil.
【24h】

Evaluation of in vivo P-glycoprotein function at the blood-brain barrier among MDR1 gene polymorphisms by using 11C-verapamil.

机译:通过使用11C-维拉帕米评估MDR1基因多态性中血脑屏障中的体内P糖蛋白功能。

获取原文
获取原文并翻译 | 示例
           

摘要

P-glycoprotein (P-gp) is a membrane protein that functions as an adenosine triphosphate-dependent efflux pump for xenobiotics at the blood-brain barrier (BBB). Polymorphisms of MDR1 gene have been reported to be associated with the expression level of P-gp. (11)C-Verapamil is considered to be one of the suitable radioligands for evaluating P-gp functions. However, the metabolites of verapamil might complicate the quantitative analysis because of their possible brain penetration. In the present study, we investigated the P-gp functional differences at the BBB between the haplotypes (1236TT, 2677TT, 3435TT vs. 1236CC, 2677GG, 3435CC) of the MDR1 gene with different quantitative analyses of (11)C-verapamil. METHODS: Thirty-three healthy male volunteers were enrolled in this study after identification of the haplotypes of the MDR1 gene. Brain PET scans with (11)C-verapamil were performed for 16 min. Integration plot analysis, which yields brain uptake clearance, was performed with the first 3-min data. Integration plot analysis was then compared with several other quantitative analyses with 16-min data (1-input, 1-tissue compartment model, and the area under the curve ratio (AUC(ratio)) between brain and plasma). RESULTS: In the integration plot, there was no difference in the absolute values of brain uptake clearance (CL(uptake)) between the haplotypes; CL(uptake) of (11)C-verapamil for the haplotypes (1236TT, 2677TT, 3435TT vs. 1236CC, 2677GG, 3435CC) were 0.053 +/- 0.011 and 0.051 +/- 0.011 mL/g/min, respectively. CL(uptake) of (11)C-verapamil in the integration plot was significantly correlated with K1 and DV(K1/k2) (DV is distribution volume; K1 and k2 are plasma and tissue rate constants) in the 1-input, 1-tissue compartment model and the AUC(ratio). CONCLUSION: On the basis of the several quantitative analyses of (11)C-verapamil, the assumption that the function of P-gp at the BBB is different between the haplotypes (3 single nucleotide polymorphisms: C1236T, G2677T, and C3435T) of MDR1 gene was not supported.
机译:P-糖蛋白(P-gp)是一种膜蛋白,可作为血脑屏障(BBB)上异源生物的依赖于三磷酸腺苷的外排泵。据报道,MDR1基因的多态性与P-gp的表达水平有关。 (11)C-维拉帕米被认为是评估P-gp功能的合适放射性配体之一。但是,维拉帕米的代谢物可能会渗透到大脑,因此可能会使定量分析复杂化。在本研究中,我们用(11)C-维拉帕米的定量分析研究了MDR1基因的单倍型(1236TT,2677TT,3435TT与1236CC,2677GG,3435CC)之间在BBB处的P-gp功能差异。方法:在确定了MDR1基因的单倍型后,本研究共纳入了33名健康男性志愿者。用(11)C-维拉帕米进行脑PET扫描16分钟。使用前3分钟的数据进行积分图分析,产生大脑摄取清除率。然后将积分图分析与其他一些具有16分钟数据的定量分析(1输入,1组织隔室模型以及脑与血浆之间的曲线比率下的面积(AUC(比率)))进行比较。结果:在积分图中,单倍型之间的脑摄取清除率的绝对值(CL(摄取))没有差异; (11)C-维拉帕米单倍型(1236TT,2677TT,3435TT与1236CC,2677GG,3435CC)的CL(摄取)分别为0.053 +/- 0.011和0.051 +/- 0.011 mL / g / min。在1输入中,(11)C-维拉帕米的CL(摄取)与K1和DV(K1 / k2)显着相关(DV是分布体积; K1和k2是血浆和组织速率常数),1 -组织隔室模型和AUC(比率)。结论:在对(11)C-维拉帕米的定量分析的基础上,假定MDR1的单倍型(3个单核苷酸多态性:C1236T,G2677T和C3435T)在BBB上P-gp的功能不同。不支持该基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号